Investors are now prioritizing profitability and competitive advantages in India's digital sector, moving beyond just tech-enabled listings. Parag Thakkar highlights Lenskart for its profitability and market potential, and expresses optimism for Tata Capital due to its growth and brand.
While the Southeast Asian nation opened its economy to U.S. multinationals and technology after Washington lifted its embargo in the 1990s, it stayed cautious over China, after their 1979 war and disputes over South China Sea boundaries. Now Beijing's influence is rising and U.S. ties are strained by tariffs.
The surprise move, revealed in a one-paragraph note by the Department of Housing and Urban Development, did not give a reason for withdrawing the plan or a timeline for reissuing it, saying only it would do so in time to govern awards for the current fiscal year.
India's private credit market is booming, attracting global investors. Structural reforms and strong developer demand are key drivers. Alternative Investment Funds are playing a crucial role, acting as new lenders for real estate projects. India is becoming a major hub for real estate credit capital in the Asia-Pacific region.
Indian markets are at record highs. Investors are reviewing asset allocation for the coming year. Naveen Kulkarni of Axis Securities PMS suggests a 10-lakh portfolio for 30-40 year olds. Equities should exceed 50%. Debt and gold will form the rest. FIIs may return in 2026. BFSI, power, and consumption sectors are expected to lead.
In the Nifty500 pack, 11 stocks' closing prices crossed above their 200 DMA (Daily Moving Averages) on December 9, 2025, according to stockedge.com's technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend. Take a look:
Since Trump's appointment of Robert F. Kennedy Jr. as health secretary, the US government has initiated a major overhaul of vaccine policy, prompting growing concerns among the medical community.
